CALA OTC
Calithera Biosciences, Inc.
1W: -66.7%
1M: -66.7%
3M: -75.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±115.6%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.001
Volume251
Avg Volume503
Beta-1.28
Dividend—
Analyst Ratings
Company Info
CEOStephanie Wong
Employees8
SectorHealthcare
IndustryBiotechnology
IPO Date2014-10-02
Websitecalithera.com
343 Oyster Point Boulevard
South San Francisco, CA 94080
US
South San Francisco, CA 94080
US
650 870 1000
About Calithera Biosciences, Inc.
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Latest News
Calithera Biosciences (NASDAQ:CALA) Shares Break Above 50 Day Moving Average – Should You Sell?
Calithera Biosciences (NASDAQ:CALA) Stock Crosses Above 50 Day Moving Average – Time to Sell?
Calithera Biosciences (NASDAQ:CALA) Shares Pass Above Fifty Day Moving Average – What’s Next?
Calithera Biosciences (NASDAQ:CALA) Stock Passes Above Fifty Day Moving Average – Time to Sell?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| PAKIANATHAN DEEPIKA | S-Sale | 1,172 | $0.39 | 2023-01-27 |
| Sjogren Eric | F-InKind | 279 | $0.45 | 2023-01-23 |
| Kuriakose Emil | F-InKind | 79 | $0.45 | 2023-01-23 |
| Molineaux Susan | F-InKind | 526 | $0.45 | 2023-01-23 |
| Wong Stephanie | F-InKind | 317 | $0.45 | 2023-01-23 |